SANTA CLARA, Calif., Aug. 30, 2018 /CNW/ -- Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing titled, "Conquering Aging: Novel Technology Disruptions in the Anti-aging Industry", on Tuesday, September 18, 2018, from 11:00 AM to 12:00 PM Eastern Time. The webinar will offer expert insight from Neelotpal Goswami, Life Sciences Senior Industry Analyst and Unmesh Lal, Life Sciences Program Manager, both from the Transformational Health Practice at Frost & Sullivan; Alex Zhavoronkov, Founder and CEO, Insilico Medicine; Frank Jaksch, Co-Founder & Executive Chairman, ChromaDex; and Edward Cox, CEO, Dthera Sciences.
For more information and to register for the webinar, please visit http://frost.ly/2pr.
As the global population rapidly ages, it is creating immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of such aging-related issues has been focused on "repair", i.e. treatment of the various age-related ailments. However, the industry's approach has gradually changed—with growing focus on prevention and management of such symptoms.
"The industry's movement towards a "prevent-manage-repair" continuum is creating opportunities for integrative approaches for age management. For instance, consumers are showing interest in dietary supplements with clinical promise such as Nicotinamide Riboside, Coenzyme Q-10 and herbal extracts such as curcumin," observed Goswami.
The "prevent-manage-repair" continuum is creating novel market opportunities for integrative approaches including aesthetics procedures, alternative therapies, and digital tools. Those approaches combined with advanced clinical therapeutics such as regenerative medicine as well as pharmacological targeting of aging (focused on telomeres, rapalogs, senescent cell targeting, mitochondria-based therapies, etc.) are key opportunities in this space.
"Digital pills that can track medication consumption will improve drug adherence, a key challenge in the treatment of the elderly population. The 'drug-as-a-service' model will impact the anti-aging space with the advent of digital therapeutics that amalgamates mobile technology with artificial intelligence (AI) and big-data analytics. This will drive technology collaborations between drug and technology companies aimed at improving drug efficacy and adherence," concluded Lal.
The informative webinar will cover key insights:
- Discover innovations in anti-aging drugs and therapies, novel nutrition, and digital tools;
- Engage with thought leaders to understand the dynamics around significant market trends, innovative business models, and game-changing companies; and
- Uncover key investment opportunities and growth potential.
The event will also be recorded and available for on-demand viewing at http://frost.ly/1ti.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.
For more information, visit ww2.frost.com or call +1 (877) 463-7678.
Frost & Sullivan
+1 (210) 348.1012
SOURCE Frost & Sullivan